Urologix, Inc.
ULGX · OTC
6/30/2014 | 6/30/2013 | 6/30/2012 | 6/30/2011 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,608 | -$4,292 | -$4,695 | $0 |
| Dep. & Amort. | $587 | $674 | $695 | $565 |
| Deferred Tax | -$36 | $1 | $35 | $0 |
| Stock-Based Comp. | $211 | $257 | $359 | $369 |
| Change in WC | $1,163 | $1,092 | $2,440 | $463 |
| Other Non-Cash | -$105 | -$447 | $472 | -$3,733 |
| Operating Cash Flow | -$1,530 | -$1,959 | -$713 | -$2,370 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$42 | -$79 | -$57 | -$272 |
| Net Acquisitions | $0 | -$1,368 | -$500 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$32 | -$8 | -$3 |
| Investing Cash Flow | -$42 | -$1,479 | -$565 | -$275 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $3,829 | $116 | $4 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $3,829 | $116 | $4 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,572 | $391 | -$1,162 | -$2,641 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,290 | $1,899 | $3,061 | $5,702 |
| End Cash | $718 | $2,290 | $1,899 | $3,061 |
| Free Cash Flow | -$1,572 | -$2,038 | -$770 | -$2,642 |